Myrna Watanabe | Jan 12, 2003 | 3 min read
Courtesy of Molecular Staging UNRAVELING MDA: Molecular Staging's MDA technology relies on a highly processive, strand-displacing DNA polymerase. As high-throughput genomics and its postgenomics successor, proteomics, are the technologies of choice for rapid screening of new pharmaceuticals, a company that establishes itself as a technology leader in both fields could be ahead of the pack: New Haven, Conn.-based Molecular Staging (MSI). In November 2002, MSI announced in rapid successi